Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Therapeutic Technologies (CTT) is a specialty pharmaceutical company focused on the development and commercialization of branded prescription products using proprietary drug delivery systems. The company specializes in reformulating proven active pharmaceutical ingredients into advanced delivery formats, such as topical patches and specialized oral formulations, to improve patient compliance and therapeutic outcomes. CTT's primary focus areas include pain management, cardiovascular health, and central nervous system disorders. By leveraging its proprietary technology, the company aims to provide safer and more effective alternatives to traditional systemic medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cambridge Therapeutics.